The purpose of this study was to examine the localization of macrophages, B-lymphocytes and osteoclasts in tumoral lesions of mammary carcinoma metastasized to bone of non-immunocompromised mice. Mouse mammary carcinoma cells (BALB/c-MC) were injected through the left cardiac ventricle into 5-week-old female wild-type Balb/c mice. The femora and tibiae of mice with metastasized cancer were extracted, and thereafter processed for histochemical analyses. The foci of metastasized tumor cells occupied the metaphyseal area, and the cell death zones could be identified within the tumor mass. Abundant tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts were found among the alkaline phosphatase (ALP)-reactive osteoblastic cell layer that covered the bone surface neighboring the metastatic lesion. In contrast, F4/80-positive macrophages/monocytes were localized adjacent to, or invading the metastatic tissue. In addition, some F4/80-positive cells were found in the aforementioned cell death zones. Unlike F4/80-positive cells, CD45R-positive B-lymphocytes did not accumulate at the surfaces of the tumor lesions, nor infiltrate into them, but were found scattered over bone marrow. Interestingly, some CD45R-positive cells were observed close to TRAP-positive osteoclasts in the stromal tissue surrounding the tumor lesion. Our findings suggest that, in the bone metastatic lesions of non-immunocompromised mice, F4/80-positive macrophages/monocytes accumulated on and/or infiltrated into the tumor nests, while CD45R-positive B-lymphocytes were associated with osteoclasts, rather than attacking metastatic tumor cells.
Metastasis is a deteriorating clinical situation in patients suffering from malignant tumors, and it occurs as the blood circulation transports tumoral cells that detach from the primary cancer lesion and eventually become seeded at secondary sites. For example, the human breast's venous drainage flows into the vertebral venous plexus, which could explain why nearly 70% of patients with breast cancer develop bone metastases (7) . Bone metastasis of breast cancer often causes patients to suffer severe complications: pain, pathological fractures, hypercalcemia, and nerve compression syndromes (9, 13, 47) . Bone metastases secondary to breast, kidney, prostate and lung cancer can induce osteolytic, osteogenic, or combined lesions depending on the interaction between tumoral cells and the host tissue. Breast car-easily observe macrophage/monocytes, lymphocytes and osteoclasts which localize at metastatic sites. F4/80 can recognize macrophage/monocyte lineage cells, but not osteoclasts in mouse bone as reported previously (34, 43) . In contrast, tartrate-resistant acid phosphatase (TRAP) staining can distinguish the osteoclastic lineage from mouse macrophage/ monocytes, though not from human macrophages which can express TRAP5a. B-lymphocytes, rather than T-lymphocytes, appear to somehow participate in bone turnover processes (5, 8, 14, 20, 27, 28) . B-lymphocytes can be phenotypically identified by the expression of the lineage marker CD45R, also referred to as B220 (6) , commonly used as a hallmark of pan B-cell in mouse (10, 33) . CD45R is not expressed in the early pro-B-cell, but it is in the intermediate pro-B-cell, late pro-B-cell and pre-B cell in mouse bone marrow (29, 49) .
Based on the above mentioned, we have examined the localization of TRAP-positive osteoclasts, CD45R-positive B-lymphocytes, and F4/80-positive macrophage/monocytes related to osteolytic metastatic lesions in immunocompetent Balb/c mice.
MATERIALS AND METHODS
Animals and tissue preparation. Twelve 5-week-old female wild-type Balb/c mice (Japan SLC, Hamamatsu, Japan) were used in this set of experiments, strictly observing the Josai International University's Guidelines for Animal Experimentation, and in compliance with the Niigata University Guidelines for Animal Experimentation. Under anesthesia with pentobarbital sodium, BALB/c-MC (mouse mammary carcinoma cells, 10 5 cells/0.1 mL) obtained from the Riken Cell Bank (Tsukuba, Japan) as reported (38) were injected percutaneously into the left cardiac ventricle of mice using a 27-gauge needle attached to a 1-mL syringe. Three weeks later, these mice were subjected to transcardiac perfusion with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The femora and tibiae were removed, immersed in the same fixative for additional 12 h, and samples designated to light microscopic observation were decalcified with 10% EDTA-2Na solution for 3 weeks at 4°C. After decalcification, specimens were dehydrated in ascending concentrations of ethanol prior to paraffin embedding. All histological sections were examined under a light microscope (Eclipse E800; Nikon, Ltd, Tokyo, Japan). Samples separated for transmission electron microscopy (TEM) processing were immersed in a mixture of 2% paraformaldehyde and 2.5% glutaraldehyde in cinomas are consistently linked to bone metastasis and often induce osteolysis (52) , thereby increasing morbidity. Much scientific effort has been put into discovering how and why breast cancer cells seem to prefer the skeleton for establishing their metastatic nests, and the microenvironment of bone per se is likely to play an important role in facilitating tumor cells' colonization and proliferation (44) .
In order to elucidate the mechanisms of these remarkable pathological events, immunocompromised animals were seeded with cancer cell lines derived from human carcinomas (17, 18, 25, 50) . As in humans, breast carcinomas commonly cause osteolytic lesions, selectively colonizing the femora and tibiae of nude mice (16) . In osteolytic metastases, osteoclasts play a key role in expanding the borders of metastatic nests (25, 37, 43) . This is supported by histological observations demonstrating osteoclastic bone resorption (2, 11, 45) , as well as by reports that the inhibited osteoclastic activities by the administration of bisphosphonate suppressed osteolysis and subsequent tumor expansion (22, 37) . As in physiological events, osteoblastic cells appear to regulate osteoclastic activity in the tumor nests through the receptor activator of nuclear factor-κB (RANK)/RANK ligand (RANKL) system (22) . Cancer cells would also contribute to bone resorption by releasing cytokines that would lead to osteoclastic activation (12, 40, 46) . Thus, immunocompromised nude mice suffering from bone metastasis have provided several clues to the interplay among osteoclasts, osteoblasts and tumor cells, as the influence of immune cells including macrophages and lymphocytes was eliminated.
However, in an immunocompetent individual, immune cells would participate in the defense against metastasizing cells. The immune response usually starts with the identification of an antigen, which is a task mainly accomplished by macrophage/monocytes and dendritic cells, while sometimes being carried out by B-lymphocytes; lymphocyte activation would come as the next step of the immune cascade (24, 36, 39) . Therefore, immune cells may negatively contribute to a favorable environment for the establishment of metastatic foci and, also, may affect the activities of bone cells. However, few reports have addressed this issue, and only a bone metastatic, immunocompetent animal model seems to be suitable for such investigation. Recently, we have demonstrated that mouse BALB/c mammary adenocarcinoma cells (BALB/c-MC) are capable of inducing osteolytic metastasis in normal mice (32, 38) . By employing this model, we may be able to described in our previous report (1) . Immunohistochemistry was conducted as aforementioned, with TRAP detection being performed thereafter.
RESULTS

Histological findings in the metastatic tumor lesion
Three weeks after the seeding of tumor cells, foci of metastasis were identified at the femoral metaphyses, neighboring the growth plate (Fig. 1A) . Metaphyseal trabecules surrounding the tumor nests seemed to have been resorbed (Fig. 1B) . There was a stromal layer separating the tumor nests from the peripheral bone surfaces. Unlike bone metastasis in nude, immunocompromised mice (21), cell death zones containing cellular debris could be found within the tumor masses (Fig. 1C) . TEM observations revealed a heterogeneous cell population in the lesion and its surroundings, with cell types such as (1) tumor cells with large cell bodies and nuclei, numerous mitochondria and translucent cytoplasm, (2) osteoblasts with abundant rough endoplasmic reticulum, which covered the bone surfaces, (3) fibroblastic stromal cells extending their cytoplasmic processes, and (4) multinucleated osteoclasts with numerous mitochondria (Fig. 1D ). These cells intermingled among the stromal tissue peripheral to the metastatic lesions.
Localization of ALP-and TRAP-positive cells in the metastatic lesion
Double staining for ALP and TRAP demonstrated that TRAP-positive osteoclasts were present within the ALP-reactive osteoblastic cell layer covering the bone surfaces close to the metastatic lesion ( Fig. 2A) . When the magnified image was observed, the ALPpositive, thick osteoblastic layer was shown to have surrounded the tumor nest, without infiltrating the body of the lesion (Fig. 2B) . Consistently, TRAP-reactive osteoclasts could hardly be seen inside the metastatic nest. Under TEM, the osteoclasts on bone surfaces displayed well-formed ruffled borders and abundant intracellular vesicles and vacuoles, keeping close association with osteoblastic cells (Fig. 2C) .
Localization of F4/80-positive macrophage/monocyte lineage cells and TRAP-reactive osteoclasts in the tumor lesion
F4/80-immunopositive macrophage/monocytes gathered in the region of the metastatic tumor nests, whereas they were sparsely found in the overall bone marrow (Fig. 3A) . These cells were seen in the stromal tissue encapsulating the tumor masses, but 0.067 M cacodylate buffer (pH 7.4) for additional 12 h. Decalcification proceeded with 5% EDTA-2Na for 4 weeks at 4°C. Specimens were postfixed with 1% OsO 4 in 0.1 M cacodylate buffer (pH 7.4) for 4 h at 4°C and, then, dehydrated with ascending concentrations of acetone, and finally they were embedded in epoxy resin (Epon 812; Taab, Berkshire, UK). Ultrathin sections derived from epoxy resinembedded samples were stained with uranyl acetate and lead citrate prior to observation under TEM (H-7100; Hitachi Co. Ltd, Tokyo, Japan) at 80 kv.
Immunohistochemistry for alkaline phosphatase (ALP), F4/80 and CD45R. Dewaxed paraffin sections were pretreated with 0.3% hydrogen peroxide for 20 min in order to inhibit endogenous peroxidase, and then immersed in 1% bovine serum albumin (BSA; Seologicals Protein Inc. Kankakee, IL) in PBS (1% BSA-PBS) for 30 min at room temperature. Sections were incubated with rabbit antiserum against tissue non-specific alkaline phosphatase (ALP) previously generated by Oda et al. (35) at a dilution of 1 : 200 for 1 h, with rat anti-mouse CD45R (Serotec Ltd, Oxford, UK) at a dilution of 1 : 100 in 1% BSA-PBS (15) for 2 h, or with a culture medium of rat hybridoma which secretes a monoclonal antibody against F4/80 for 2 h (34). For CD45R and F4/80 staining, we did not use enzyme pretreatment or heat-activation, and primary incubations were all performed at room temperature. Slides for ALP detection were subsequently treated with horseradish peroxidase (HRP)-conjugated goat anti rabbit IgG (Chemicon International Inc., Temecula, CA) at a dilution of 1 : 100 at 4°C for 1 h. The histological sections incubated with antibodies against CD45R or F4/80 were secondarily incubated with HRP-conjugated rabbit anti-rat IgG (Chemicon) at a dilution of 1 : 100 for 1 h. All immunoreactions were visualized with diaminobenzidine staining, and all sections were slightly counterstained with methyl green.
Tartrate-resistant acid phosphatase (TRAP) detection. For TRAP-detection, sections were rinsed with PBS and processed using the Azo-dye method according to Burstone (3) . The incubation medium was composed of 0.01% naphthol AS-BI phosphate (Sigma, St. Louis, MO), 0.06% fast red violet LB salt (Sigma) and 100 mM L-(+) tartaric acid (Nakarai Tesque, Co., Kyoto, Japan) in 0.1M acetate buffer (pH 5.2). The incubation was carried out for 30 to 45 min at 37°C. Double staining for ALP/TRAP, CD45R/TRAP and F4/80/TRAP were performed as competence. However, as shown in Fig. 1C , the central portion of the metastatic foci showed cell debris despite the small size of the lesion, a finding that differs from those derived from immunocompromised nude mice (25) . The existence of such a cell death zone might be the result of protective actions of a proper immune system against tumoral, exogenous cells. Consistently, though not statistically analyzed, the size of tumor nests did not seem to rapidly increase in mice with immune competence, when compared with that of our previous report using nude mice (43) .
Interestingly, F4/80-positive macrophage/monocytes invaded the tumor masses and accumulated at the cell death zone, while CD45R-positive B-lymphocytes did not. TEM observations revealed macrophages engulfing cellular debris in the tumor nests. These findings differ from those of our previous experiments with nude mice, in which F4/ 80-positive cells were sparsely distributed along the bone marrow (43) . As nude mice do not possess mature T-lymphocytes, the finding that macrophages accumulated at the tumor lesion suggests that T-lymphocytes are involved in macrophage activities. The accumulation of F4/80-positive macrophage and the presence of a cell death zone indicate that macrophages are at the foremost line of combating tumor cells. Although macrophages serve for antigen-presentation against tumor cells, B-lymphocytes are also thought to be involved in antigen capture and presentation of MHC class II molecules, a process mediated by their surface antigen receptor-the B-cell receptor (48) . As shown in previous studies (31) and in ours, however, CD45R-positive B-lymphocytes did not invade into tumor nests. While bone marrow CD45R-positive B-lymphocytes seem immature, mature B-lymphocytes in secondary lymphatic organs may secrete antibodies against tumor cells, though this was not assessed in the current study. Thus, macrophages/monocytes, rather than B-lymphocytes seem to easily attack the metastasized tumor cells in bone tissue.
It is interesting that these CD45R-positive cells were, in part, associated with osteoclasts (Fig. 4C) . Since many reports have suggested that B-lymphocytes affect osteoclastogenesis and subsequent osteoclastic activity, it is feasible that CD45R-positive cells affect osteoclasts in the metastasized lesion. An increased number of B-lymphocytes due to estrogen deficiency has been reported to stimulate bone resorption (30, 41) . On the other hand, interleukin 7 receptor-knockout mice, which lack B-lymphocytes because of an arrest of B-lymphopoiesis at the were also found inside the tumor bodies associated with the cell death zone (Figs. 3B, 3C) . Thus, macrophage/monocyte cells seemed to lie adjacent to, or else, to invade the tumor nests, while TRAP-positive osteoclasts accumulated on the peripheral bone surfaces (Fig. 3D) . As the two cellular types occupied opposing zones, no substantial association between them could be observed. TEM observations showed macrophages engulfing cellular debris in a region full of degraded cellular elements close to the tumor cells (Fig. 3E) .
Localization of CD45R-positive cells and osteoclasts in the tumor lesion
Immunoreactivity for CD45R, a hallmark of B-lymphocyte lineage cells (10, 33) , was widely observed in the bone marrow (Fig. 4A ). CD45R-positive B-lymphocytes formed small clusters and, unlike F4/80-positive macrophage/monocyte cells, did not accumulate or infiltrate into the metastatic nest (Fig. 4B) . Some B-lymphocytes would, however, be identified close to TRAP-positive multinucleated osteoclasts in the stromal tissue surrounding the tumor lesion, as well as TRAP-positive mononuclear cells in the bone marrow (Fig. 4C) . TEM imaging showed osteoclasts with exuberant ruffled borders in close association with lymphocytes and tumor cells (Fig. 4D ).
DISCUSSION
In this study, wild-type, non-immunocompromised Balb/c mice were shown to develop bone metastasis after an injection of BALB/c-MC cells. To our knowledge, there are few, if any, studies with normal animals depicting histological data on the distribution of immune cells in bone metastatic lesions. Consistent with our previous reports (25, 38, 43) , metastatic foci were observed in femoral metaphyses, at the region close to the growth plate. Thus, the onset of a metastatic tumoral site may not be affected by the presence or absence of an immune system but, instead, may depend on the existence of a favorable environment like the one at the chondroosseous junction, where rich microvasculature and matrix degradation co-exist (26, 51) . In this work, as shown in Figs. 2A and 2B , abundant TRAP-positive osteoclasts were restricted to an ALP-positive cell layer covering the bone surfaces, findings which were in accordance with our previous reports (25, 43) . Hence, adherence of tumor cells and establishment of a metastatic focus in bone, as well as osteoclastic stimulation, seem not to be linked to immune pro-B cell maturation stage, display increased trabecular bone volume (30) . Osteoclastic stimulation by B-lymphocytes may account for the idea that these cells would be a source of endogenous RANKL in the bone marrow (4, 19, 27) . Shibata et al. also demonstrated that malignant B cells aberrantly express functional RANKL as well as vascular endothelial growth factor, thereby enhancing osteoclastogenesis (42) . These previous reports indicate that B-lymphocytes are involved in osteoclastogenesis and subsequent bone resorption in both physiological and pathological states. As shown in this study (Fig. 4C) , CD45R-positive cells were in close proximity, in the bone marrow, to bone resorbing osteoclasts and to TRAP-positive mononuclear cells, probable preosteoclasts. As the RANK/ RANKL signaling would be mediated by cell-to-cell contact, it is likely that CD45R-positive B-lymphocytes contact osteoclasts in order to, in part, regulate osteoclastic formation and activities in the circumstance of osteolytic metastasis. Alternatively, other investigators have suggested that B-lymphocytes, in the early stage of differentiation and given the right pathological conditions, may have the potential to differentiate into osteoclasts (5, 8, 14, 20, 27) . However, we could not find evidence supporting this postulation, for we could hardly see TRAP-and CD45R-double positive cells. Besides, the clusters of CD45R-positive cells were evenly distributed in the bone marrow and were absent within the osteoblastic layer, where osteoclastic precursors should undergo final differentiation (22, 23) .
In summary, in bone metastatic lesions formed in wild-type, immunocompetent Balb/c mice, F4/ 80-positive macrophage/monocytes were observed surrounding and infiltrating the tumor nests. Yet, CD45R-positive B-lymphocytes were spatially associated with osteoclasts on the bone surfaces facing the tumor nests, rather than directly attacking the metastatic tumoral cells.
